MAPT and Cognitive impairment: It has been reported that δ-secretase cleaves Tau protein at residues N255 and N368 sites, promoting Tau hyperphosphorylation and aggregation, leading to neuronal toxicity and causing cognitive impairment in AD patients (Kang et al., 2020).